BPI-15086
Product Specifications
CAS Number
1644502-33-9
Target
EGFR
Related Pathways
Tyrosine Kinase/Adaptors, JAK/STAT signaling, Angiogenesis
Bioactivity
BPI-15086 is an orally active, effective, irreversible inhibitor selective for mutations, targeting both EGFR and the T790M resistance mutation tyrosine kinase. It can be utilized in the study of non-small cell lung cancer.
Smiles
O=C(C=C)NC1=CC(NC2=NC=C(Cl)C(=N2)NC=3C=CC=CC3C(=O)C(=O)N(C)C)=C(OC)C=C1N4CCN(C)CC4
Molecular Formula
C29H33ClN8O4
Molecular Weight
593.08
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15164704 1 Vial
Lentiviral mouse Rnf114 shRNA (UAS) - Lentiviral mouse Rnf114 shRNA (UAS, iRFP) plasmid
Sign In for Pricing
View Details 
MBS7040143-01 0.02 mg
Recombinant Schizosaccharomyces pombe Uncharacterized glycosyltransferase C17G8.11c (SPAC17G8.11c)
Sign In for Pricing
View Details MBS7040143-02 0.1 mg
Recombinant Schizosaccharomyces pombe Uncharacterized glycosyltransferase C17G8.11c (SPAC17G8.11c)
Sign In for Pricing
View Details MBS7040143-03 5x 0.1 mg
Recombinant Schizosaccharomyces pombe Uncharacterized glycosyltransferase C17G8.11c (SPAC17G8.11c)
Sign In for Pricing
View Details 